Non-alcoholic fatty liver disease (NAFLD) is an increasingly common and potentially serious condition, which has emerged with the obesity epidemic. This disease can progress to cirrhosis and hepatocellular cancer. Associated comorbidities, such as cardiovascular disease and type 2 diabetes, are common. Obesity is the key risk factor and diet appears to be a critical factor in the pathogenesis of NAFLD. We reviewed studies undertaken on human subjects investigating which dietary components initiate excess hepatic triglyceride deposition. Most experimental diets used high-calorie excesses, or extreme proportions of fat or carbohydrate, not typical of current dietary patterns. Hypercaloric diets, where the additional calories were predominantly either fat or carbohydrates, increased intrahepatocellular lipids. The type of fat appeared important, with diets high in saturated fatty acids favoring hepatic fat accumulation which was substantially lower with polyunsaturated fatty acids. The effect of dietary fructose on markers of NAFLD did not appear to be worse than that of glucose. The initiation of excess hepatic triglycerides is likely to be a complex interaction of energy and nutrients with more than one dietary factor involved. It was not possible to disentangle the hepatic effects of excess energy from that of different macronutrient distributions in current literature. Further investigation is needed to determine the type of diet that is likely to lead to the development of NAFLD. A better understanding of the contribution of diet to pathogenesis of NAFLD would better inform prevention strategies.
Introduction
Non-alcoholic fatty liver disease (NAFLD), defined as excessive lipid accumulation in hepatocytes (>5% wet weight) in the absence of excess alcohol intake or other pathological causes, has emerged in parallel with the obesity epidemic, 1 with reported prevalence rates as high as 30%. 2, 3 The disease encompasses a spectrum of conditions ranging from simple fatty liver (steatosis) through to fat deposition with inflammation and fibrosis (nonalcoholic steatohepatitis or NASH) as shown in Figure 1 . 4 NAFLD can progress to cirrhosis and hepatocellular cancer, 5 and is becoming one of the leading causes of terminal liver failure and reasons for liver transplant. 6, 7 While most individuals have simple fatty liver disease and do not develop the more serious forms of the disease, all those with NAFLD have an increased risk of associated extrahepatic conditions, particularly cardiovascular disease 8, 9 and type 2 diabetes. 10 The risk of NAFLD increases with age, [11] [12] [13] but obesity is the key risk factor. Diet is most likely a contributing factor. However, it is unclear if a particular dietary composition or simply excess calories, irrespective of the macronutrient composition of the diet, contributes to the pathogenesis of NAFLD. 5 This article provides an overview of NAFLD and insulin resistance (IR), and reviews the literature on dietary components and dietary patterns that may initiate excess hepatic fat deposition in human subjects.
Methods
Databases were systematically searched in January 2017. Databases searched included: MEDLINE (PubMed), Scopus, Web of Science, Cochrane CENTRAL Register of Controlled Trials; Cochrane Database of Systematic Reviews, clinicaltrials.gov, EMBASE, and SIGLE (System for Information on Grey Literature). Keywords searched included: "excess fat" OR "fat accumulation" OR lipid* OR "De novo lipogenesis" OR DNL OR Triacyglycer*AND diet OR "dietary pattern*" OR "dietary habit*" OR "dietary component*" OR "dietary make*up" OR "dietary composition" OR "composition of diet" OR overfeed* OR "hypercaloric diet*" OR "isogenic diet*" AND liver OR hepatic AND Human AND Initiat* OR trigger OR factor AND NAFLD OR "Non*alcoholic fatty liver disease". Articles and reviews were limited to those published in English and studies investigating humans. Animal studies were excluded by NOT rat* or mice.
The title and abstract were reviewed first by KPHS for relevance. If the article or review was relevant, it was read in full and assessed for inclusion criteria. Studies or reviews that had a measure of liver function or steatosis (either by radiological imaging or liver enzymes), investigated an adult population, and some dietary aspect either by observation or by intervention (using a validated measure of dietary assessment) were reviewed in full by KPHS and KJC.
Overview of NAFLD and IR
Hepatic steatosis is the net result of a positive balance of fatty acids (FAs) with excess FAs stored as triglycerides in the liver. Implicit in this dysregulation of FA metabolism is IR, a diminished cellular response to insulin. 14 Normally, insulin is released in response to food consumption and increased blood glucose levels, thereby mediating the cellular uptake of glucose in skeletal muscle, adipose tissue, and liver, and suppressing endogenous production of glucose through lipolysis, glycolysis, and gluconeogenesis. In IR, the cellular insulin signaling pathway is defective and cells cannot readily absorb glucose from the bloodstream, thereby leading to hyperglycemia. This stimulates further insulin production resulting in hyperinsulinemia. High insulin levels do not suppress lipolysis, gluconeogenesis, or glycolysis. 14, 15 An overview of the metabolism of glucose and FAs in NAFLD is shown in Figure 2 . The current understanding is that the pathological process of IR begins in the periphery in both musculoskeletal cells and adipose tissue. Unsuppressed lipolysis in adipose tissue increases levels of circulating free FAs (FFAs), which are either metabolized through β-oxidation or stored in the liver. Accumulation of excess FAs in the liver promotes hepatic IR. The cycle propagates itself as hepatic IR leads to increased glucose output through gluconeogenesis and glycolysis, as well as de novo lipogenesis (DNL), further promoting peripheral IR. 16, 17 Glycerol is also released during lipolysis, and this provides a further substrate for gluconeogenesis.
In IR, the combination of increased gluconeogenesis and impaired cellular uptake of glucose exacerbates both hyperglycemia and hyperinsulinemia, further stimulating DNL and increased production of FFAs, which also promote DNL. 16, 17 Glucose also stimulates DNL directly in the liver and indirectly via hyperinsulinemia, which also further exacerbates the already dysregulated FA metabolism. 15, 18, 19 DNL is also indirectly promoted via the transcription factors, sterol regulatory element-binding proteins, and carbohydrate-responsive element-binding protein. Sterol regulatory element-binding proteins, stimulated by insulin, regulate the genes involved in DNL in the liver, and carbohydrate-responsive element-binding proteins released in response to glucose activate enzymes involved in glycolysis and lipogenesis. These actions also increase circulating FFAs. 20 
Diet
Descriptions of dietary patterns among patients with NAFLD from observational studies do not contribute much to our understanding of possible dietary triggers of hepatic fat accumulation. These descriptive studies in patients with NAFLD [21] [22] [23] [24] [25] [26] [27] [28] provide a snapshot of dietary intakes at a single point in time, which does not necessarily reflect the dietary pattern(s) that may have contributed to the development of NAFLD. Furthermore, accurate assessments and measurements of dietary intakes are difficult as most records use self-reported estimated portions rather than weighed food records. Commonly used dietary measures are 3-or 7-day food records which at the most provide a 1-week description of food intakes. Food frequency questionnaires, which give some indication of dietary patterns over time, are also used. Recognized problems with these methods include recall bias and inaccurate estimates of volumes and weights of consumed foods. 29 Because of these methodological problems, experimental studies have sought to determine the effect of different diets and dietary patterns on hepatic fat accumulation and liver function. We found few such published studies conducted on human subjects (n = 19), but they provide some insights. These experimental studies are summarized in Table 1 .
Excess calories. Consumption of excess calories, either as fat or carbohydrates, can increase hepatic fat content within a few days. Overfeeding 10 healthy lean men, all with a normal liver, for 4 days with a high-fat diet that increased energy intake by 30% almost doubled intrahepatocellular lipids from 12 to 22 mmol/kg wet weight (P < 0.02) as measured by 1H-magnetic resonance spectroscopy (H-MRS). Most of the additional energy was derived from saturated fat (mainly dairy products), with total dietary fat comprising 46% of total energy (TE) consumed. 30 Similarly, when 15 healthy normal weight men increased their dietary energy intake by adding 800 mL of cream (11 000 kJ) daily for 3 days, mean levels of hepatic triglycerides, plasma triglycerides, and non-esterified FAs significantly increased by 2.25% (P = 0.001), 1.6 mmol/L (P = <0.001), and 0.38 mmol/L (P = 0.002), respectively. 31 When 10 pairs of healthy men aged 20-25 years consumed excess energy (5000 kJ) as either fat (58% TE) or carbohydrates (78% TE) for 21 days, their body weight and fat mass increased by a similar amount irrespective of whether the additional calories were consumed as fat or carbohydrates. 32 In the men who consumed the hypercaloric high-carbohydrate diet, fractional hepatic DNL (as measured by mass isotopomer distribution analysis) increased (up to 10-fold), suggesting carbohydrates are converted to fat by lipogenesis (hepatic and extrahepatic). Overfeeding healthy men (n = 20) and women (n = 20) with an additional 1250 kcal per day (and an overall diet macronutrient distribution of 45% fat, 15% protein, and 40% H-MRS All consumed a balanced isocaloric control diet first, then this diet was supplemented with one of the following five overfeeding diets: 1.5 g fructose/kg/day (F1.5) (n = 7), or 3 g fructose/kg/day (F3) (n = 17), or 4 g fructose/kg/day (F4) (n = 10), or 3 g glucose/kg/day (G3) (n = 11), or 30% excess energy as saturated fat (fat30%) (n = 10)
All diets 6-7 days F3, F4, G3, and fat30% diets all significantly increased intrahepatic lipid content by 113 AE 86% (P < 0.05), 102 AE 115% (P < 0.05), 59 AE 92% (P < 0.05), and 90 AE 74% (P < 0.05) as compared to control, respectively F4 and G3 diets also increased hepatic glucose production by 16 AE 10% (P < 0.05) and 8 AE 11% (P < 0.05) (Continues) carbohydrates) for 1 month significantly increased body weight and liver fat as measured by computed tomography (CT) scan, independent of gender (P ≤ 0.001). 33 When healthy lean individuals consumed additional calories as fast food with the goal of gaining 5-15% of their body weight over 4 weeks, there was a significant increase in hepatic triglyceride content as measured with H-MRS from 1.1 AE 1.9 to 2.8 AE 4.8% (P = 0.003). 34 Energy intake more than doubled during the study (2273 AE 558 to 5753 AE 1495 kcal/day), whereas the macronutrient distribution stayed similar with a slight increase in TE from fats.
Carbohydrate overfeeding of an additional 1000 kcal per day from sugary drinks in 16 overweight participants (5 men and 11 women) rapidly increased liver fat content by 27% (as measured by magnetic resonance imaging [MRI]) over 3 weeks with a concurrent 2% increase in body weight.
35 DNL (as measured by the lipogenic index 36 ) and very low-density lipoprotein (VLDL) triglycerides were also increased in proportion to liver fat (ratios: 2.1 AE 0.3 compared with 3.2 AE 0.5; P < 0.05 and 2.1 [1.9-2.3] compared with 2.6 [2.4-4.1], P < 0.005, respectively) but only in those participants with a certain genotype (wild-type genotype [PNPLA3-148II]) of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene. A 6-month hypocaloric diet reversed the weight and liver fat gain. 35 The timing of when excess energy is consumed may also be important in the pathogenesis of NAFLD. The effect of excess calories (high carbohydrate or high carbohydrate high fat) consumed either between meals or as part of the three main daily meals for 6 weeks in healthy men with a normal body mass index (BMI) was studied. 37 The source of carbohydrates was sugar in the form of sucrose-sweetened soft drinks (50% glucose/50% fructose), and the high carbohydrate high fat excess calories were consumed as a commercial liquid meal containing 49% TE as carbohydrate (maltose and polysaccharides) and 35% TE as mainly unsaturated fat. All four intervention groups gained weight, but a significant increase in intrahepatocellular lipids was observed only in the men who consumed the excess calories between meals (P = 0.03). Intrahepatocellular lipids increased only in the groups with increased meal frequency and not in those who simply increased meal size. The percentage increase was greatest among men consuming the between-meal snacks in the form of sugar-sweetened beverage (from 1.49 AE 0.95 to 3.10 AE 2.16%, P = 0.043) compared with both carbohydrate and fat (from 0.98 AE 0.91 to 1.38 AE 1.26%, P = 0.018). No other similar studies were identified.
Dietary fat. The proportion of fat in the diet, as well as the type of fat, appears to influence hepatic fat deposition in both overweight and normal weight individuals. A crossover study of 10 metabolically healthy obese women found that a 2-week high total fat (56% TE) isocaloric diet, of which half was consumed as saturated FAs (SFAs), significantly increased liver fat by 35%, whereas a 2-week low total fat (16% TE) isocaloric diet significantly decreased liver fat by 20% (P = 0.042). 38 A similar 3-week study of 20 overweight men with healthy livers found that intrahepatic lipids significantly decreased by 13% with an isocaloric low-fat (20% TE) diet, but increased by 17% with an isocaloric high-fat (55% TE) diet (P = 0.047). 39 The type of fat in these two diets was not specified, and body weight was not affected by either of these two short-term isocaloric diets. In a randomized control trial, 39 normal weight men consumed an extra 750 kcal per day, either as SFAs or polyunsaturated FAs (PUFAs), in addition to their habitual diet for 7 weeks. 40 Body weight increased by 1.6 kg in both groups, but the absolute increase in the percentage of liver fat was significantly higher in the SFA group compared with the PUFA group (0.56% vs 0.04%, P = 0.033).
Diets rich in vegetable n-6 PUFAs have been shown to significantly decrease liver fat compared with diets rich in saturated fat. When 61 abdominally obese, free-living men and women were randomized to consume a diet rich in vegetable n-6 PUFAs or a diet rich in saturated fat (mainly from butter) for 10 weeks, a significant decrease in liver fat, as measured by MRI and H-MRS, was observed in the PUFA-rich diet group. 41 At baseline ,mean liver fat content was the same for the two groups: PUFA diet (3.2%, 1.0-6.6 [H-MRS]) and SFA diet (3.2%, 1.3-7.7 [H-MRS]). During the experimental diets, liver fat decreased in the PUFA diet group and increased in the SFA diet group. The between-group difference in the relative change in liver fat from baseline was 16% as measured by MRI (P < 0.001) and 34% as measured by H-MRS (P = 0.02). Unlike other studies, participants in this study were instructed to change the type of fat in their diet without altering their total fat or the type and amount of carbohydrates and protein. While there was no change in dietary macronutrient proportions (as measured by 3-day diet records), the TE consumed by both groups increased slightly, and nonsignificant increases in body weight were observed (0.4 AE 1.4 kg in the PUFA group and 0.8 AE 1.6 kg in SFA group).
Carbohydrate. Most experimental studies investigating the effect of carbohydrate on liver fat have focused on the monosaccharide, fructose, which is primarily metabolized in the liver, whereas glucose is mostly metabolized in extrahepatic tissues. This difference in metabolic pathways has advanced the hypothesis that fructose is more likely to increase hepatic fat content. However, studies to date suggest that the hepatic effect of fructose seems to be a function of high dietary intakes contributing excess energy rather than an effect of the fructose itself. [42] [43] [44] Isocaloric exchange of fructose for other types of carbohydrates has not been shown to increase hepatic fat or liver enzymes in healthy individuals. 42 A controlled feeding study compared the effect of 2-week isocaloric and 2-week hypercaloric diets containing either high fructose (25% TE) or high glucose (25% TE) consumed as drinks in 32 centrally obese but otherwise healthy men. 45 Consumption of the hypercaloric diets, irrespective of the sugar type, increased body weight, liver and serum triacylglycerides, and liver enzymes. No significant hepatic changes were observed among the men who consumed either the high-fructose or the high-glucose isocaloric diets. However, in another similar but longer study, 32 overweight or obese adults (BMI: 25-35 kg/ m 2 ) with stable weights also consumed 25% of their energy requirements as either glucose-sweetened (n = 15) or fructosesweetened (n = 17) drinks for 10 weeks. 46 While both dietary groups had similar weight gains (+1.8% with glucose and +1.4% with fructose), hepatic DNL, markers of altered lipid metabolism, visceral adiposity, and IR were significantly increased only in the group that consumed the fructose-rich diet. This latter study suggests that fructose may contribute differently to the pathogenesis of NAFLD than other monosaccharides, at least in those who are overweight or obese, but this difference does not appear to be apparent if fructose or other monosaccharides are consumed as excess energy.
As described above, 36 the disaccharide, sucrose, which is a combination of fructose (50%) and glucose (50%), has been shown to significantly increase liver fat (as measured by MRI), at least when it is the main source of excess calories. When 47 overweight individuals were randomly assigned to consume one of the four different test drinks (1 L of sucrose-sweetened regular cola and an equivalent amount of calories consumed as milk, aspartame-sweetened diet cola, or water) daily for 6 months, the change in liver fat between baseline and 6 months was substantially higher in the sugar-sweetened cola group compared with all other groups. 47 The relative increase in the accumulation of liver fat in this group was 143% compared with the milk group (95% CI: 50, 236; P < 0.05), 139% compared with the diet cola group (95% CI: 50, 227; P < 0.05), and 132% compared with the water group (95% CI: 43, 222; P < 0.05). This was observed despite no significant changes in participants' fat mass.
Nutrient interactions. Dietary intake, of course, is not limited to a single nutrient, but a number of different nutrients of varying amounts and proportions, and they can interact with each other. The different potential nutrient interactions can have an impact on nutrient bioavailability, and may influence hepatic fat accumulation. However, the number of studies specifically examining the effect of different diet compositions or nutrient interactions on hepatic fat accumulation is small. These studies have examined glycemic index (GI), dietary fiber, fish oil, and amino acid supplementation.
The effect of two different 4-week isoenergetic diets on hepatic fat accumulation was examined in 35 older aged nondiabetic but overweight adults with normal liver enzymes. 48 They were randomized to either a low-fat (25% TE), lowsaturated fat (7% TE), and low-GI (GI < 55) isoenergetic diet (n = 20, men n = 7, mean BMI: 28.1) or a high-fat (45% TE), high-saturated fat (25% TE), and high-GI (GI > 70) isoenergetic diet (n = 15, men n = 6, mean BMI: 28.1). Body weight did not change between baseline and 4 weeks in either group, but liver fat as measured by H-MRS decreased significantly in the group that consumed the low-fat/saturated fat/GI diet (P = 0.002 unadjusted; P < 0.05 adjusted for age and sex), and there was no change in the group that consumed the high-fat/saturated fat/GI diet. Another study also examined the effect of two different isoenergetic diets (high monounsaturated FA [MUFA] and moderately high carbohydrate/high fiber/low GI) with or without exercise on hepatic fat. Participants were overweight or obese and had type 2 diabetes with satisfactory glycemic control. 49 In this factorial 2 × 2 randomized parallel group study, the percentage reduction in liver fat (as measured by H-MRS) was significantly greater in the group that consumed an isoenergetic high-MUFA (28% TE) diet with (−25%) or without exercise (−29%) compared with the group who consumed an isoenergetic higher fiber (28 vs 10 g/100 kcal), higher carbohydrate (52% vs 40% TE), lower GI (60% vs 95%) diet with (−4%) or without exercise (−6%) (P = 0.006). Body weight and waist circumference did not change in any of the groups in this study.
Two further studies suggest that dietary supplementation may moderate the effect of high-fructose diets. In a small study, fasting plasma triglyceride levels increased when seven healthy men with a normal BMI consumed fructose (3 g per kg of body weight per day as a 20% fructose solution with the three main meals) in addition to an isoenergetic diet (15% protein, 35% fat, and 50% carbohydrates) for 6 days. The increase in plasma triglycerides was significantly less if fish oil was also consumed. 50 The mean triglyceride level was 37% lower when the highfructose diet was supplemented with fish oil (P < 0.05), but levels were both significantly higher compared with the control diet and fish oil supplemented only diet (P < 0.05). A similar pattern was observed for DNL, except the difference between the high-fructose diet and high-fructose plus fish oil diet was not statistically significant. Other metabolic derangements induced by the high-fructose diet were not however diminished by the fish oil supplementation.
Amino acids may also moderate the effects of high fructose overfeeding (3 g fructose per kg per day drunk at five different times during the day). In a 'proof-of-concept' 6-day crossover trial of fructose overconsumption with or without 20 g essential amino acid supplementation daily in nine healthy men, IHCL (intrahepatocellular lipid concentrations) increased in both groups. 51 However, when compared with the control diet, the increase in liver fat during the high-fructose amino acidsupplemented diet was 16.1% lower than with the high-fructose no supplementation diet (control diet, 1.27 AE 0.31; high-fructose diet, 2.74 AE 0.55; high-fructose and amino acid diet, 2.30 AE 0.43 vol %; P < 0.05). Unlike the fish oil supplementation study, 50 essential amino acid supplementation did not significantly influence the increase in plasma triglycerides.
Discussion
Diet is an important factor in the pathogenesis of NAFLD. The limited number of human studies investigating which dietary components initiate excess hepatic triglyceride deposition suggest that more than one dietary factor may be involved. Excess energy intake can increase hepatic fat accumulation, and the effect is relatively rapid occurring within days to weeks. Whether the additional energy is from fat or carbohydrates does not appear to matter, as both high-fat and high-carbohydrate hypercaloric diets can increase intrahepatocellular lipids. 30, 32, 33, 35 While the type of fat appears to be influential, with diets high in SFAs (up to 20% TE) increasing hepatic fat compared with diets high in PUFAs (up to 12.9% TE) 40, 41 or MUFAs, 49 evidence relating to the potentially different effects of different carbohydrates is limited, because very few studies have examined this specific issue.
The experimental studies examining the effect of excess energy on liver fat tested diets with disproportionately high levels of excess calories and extreme proportions of macronutrients. These experimental diets are not typical of usual daily diets consumed by most individuals, and patients with NAFLD generally consume diets of moderate macronutrient content, [25] [26] [27] Furthermore, the experimental diets were of a short duration, with some lasting only 3-4 days. 30, 31 Consumption of such extreme diets for longer durations would have been unethical as weight gain and metabolic derangements were commonly observed, even after 3 days. It is likely that NAFLD probably develops over time and without extreme dietary intakes.
Experimental hypercaloric or isocaloric diets with a higher than recommended proportion of total fat (55-56% TE) or a high proportion of saturated fat (16% TE) both increased hepatic fat deposition. [38] [39] [40] This is biologically plausible as a high intake of total dietary fat directly increases circulatory FFAs, which leads to increased hepatic fat uptake and DNL. Furthermore, mechanistic studies in mice have observed that high-fat diets also upregulate adipogenic genes involved in DNL and FFA uptake, further increasing DNL and the development of hepatic steatosis. 52 In contrast, increasing evidence suggests that PUFAs, specifically omega-3 FAs, have beneficial metabolic effects and positively influence cardiovascular and NAFLD risk factors including hypertriglyceridemia. 53, 54 Observational dietary studies among those with NAFLD and non-alcoholic steatohepatitis suggest that the consumption of dietary omega-3 FAs is often lower than recommended, 23, 55 and when a diet with sufficient PUFAs (14% TE) is consumed as part of a balanced isocaloric diet, this appears to be protective against the development of NAFLD. 41 Further animal studies have shown that proportionally higher intakes of PUFA, particularly omega-3 FAs, decrease hepatic steatosis by promoting lipid oxidation and suppressing lipid synthesis and uptake of FAs. 56 Long-chain FAs, such as omega-3, influence the transcription of regulatory genes by interacting with some ligandactivated nuclear receptor proteins, including peroxisome proliferator-activated receptors (PPARs). 56, 57 Oxidized omega-3 FAs have a high affinity for peroxisome proliferator-activated receptors, which modulate the metabolism and storage of dietary lipids by sensing FAs and regulating genes involved in β-oxidation, FA transport, and hepatic glucose transport. 57 PUFAs also inhibit sterol regulatory element-binding protein-1, and thus the expression of genes involved in hepatic DNL is reduced. 58, 59 Excess hepatic fat deposition following high-carbohydrate diets appears to be a function of energy, although fructose metabolism differs from that of glucose. 42 Glucose is primarily metabolized in extrahepatic tissues, whereas fructose is primarily metabolized in the liver, bypassing glycolytic pathway rate limiting steps and providing unregulated substrate for DNL. 60 Although fructose is thought to have a more detrimental effect on the liver than glucose because of the different metabolic pathways, this has not been demonstrated experimentally. In the few small published studies comparing the hepatic effects of high fructose-and high glucose-containing diets in both overfeeding and isocaloric diets, no demonstrable differences on hepatic fat accumulation and liver enzymes were observed. 43 , 45 Stanhope et al. 46 reported that hepatic DNL, markers of altered metabolism, visceral adiposity, and IR all increased when a high fructose-containing diet (25% TE) was consumed compared with a similarly high glucose-containing diet (25% TE), but the amounts of fructose and glucose were especially excessive. In contrast, when individuals consume fructose in amounts typical of many Western dietary patterns (defined as consuming up to the 95th percentile of the highest population intake), there does not appear to be any biologically relevant changes in triglycerides or body weight. This has been observed in healthy normal weight individuals, and overweight or obese individuals. [61] [62] [63] In conclusion, NAFLD has emerged within the context of the current obesogenic environment. The limited evidence suggests that excess energy intake induces excess hepatic fat accumulation, and that the source of excess energy may affect this pathogenic process. However, studies have used experimental diets with high calorie excesses and large proportions of fat or carbohydrates (most often in the form of simple sugars), which are not typical of current dietary intakes and dietary patterns. This is an important confounding factor, and thus, to date, it is not possible to disentangle the effect of excess energy from the different macronutrients (fat and carbohydrates). The development of NAFLD is likely to be a result of the complex interaction of energy and nutrients. Further investigation is needed to determine the effects of diets more representative of current dietary patterns and the type of diet that leads to the development of NAFLD. A better understanding of the contribution of diet to the pathogenesis of NAFLD would better inform prevention strategies.
